Abstract:Introduction: SARS-CoV-2 infection can lead to a broad range of neurological manifestations such as olfactory and gustative disorders, myalgias, headache, and fatigue but also more rare and severe neurological pictures such seizures, encephalitis, and cerebrovascular diseases. It is still unknown if the underlying pathophysiological mechanism is the direct cytotoxic effect of the virus on central nervous system or if the related systemic inflammation leads to cerebral suffering and neurological symptoms. Studying neurological manifestations of SARS-CoV-2 infection among solid organ transplant recipients, who take immunosuppressive drugs, may help to shed light on this topic. Methods: We enrolled a total of 73 solid organ transplantation recipients (kidney, liver, lung, heart and combined) with a history of SARS-CoV-2 infection (in the period between July 2020 and June 2021). We collected all demographic and clinical general information and, through phone interviews, we registered retrospectively the occurrence of neurological symptoms during the acute phase of infection and within the next 6 months. Results: Approximately 27.4% (20/73) of patients needed hospitalization during the infection, 25.3% (18/73) were treated with oxygen therapy, and only one patient was admitted to the Intensive Care Unit for mechanical ventilation. Almost 74% (54/73) of patients reported at least one neurological symptom/disease. The most frequent neurological complications were myalgia (57.5%), headache (37%), and hyposmia/hypogeusia (37%). Need of oxygen therapy during the SARS-CoV-2 infection was statistically significantly associated to neurological complications ( p = 0.0344). Pre-infection neurological comorbidities and immunosuppression levels (higher levels of tacrolimus and also being on steroids) did not modify the probability to have neurological manifestations. Discussion: Frequency of headache was comparable with the same self-reported symptom in the general population, while hyposmia/hypogeusia was more frequent in our cohort of transplant recipients. Higher level of tacrolimus as well as being on steroids did not result protective against neurological manifestation. Lastly neurological symptoms occurred more frequent in more severe cases of infection.

Solid organ transplant-related central nervous system infections

Recent advances in understanding and managing infectious diseases in solid organ transplant recipients

Viral meningoencephalitis in pediatric solid organ or hematopoietic cell transplant recipients: a diagnostic and therapeutic approach

Monocentric, Retrospective Study on Infectious Complications within One Year after Solid-Organ Transplantation at a Belgian University Hospital

Prevention and therapy of viral infections in patients with solid organ transplantation

Clinical Characteristics and Outcomes of Endemic Mycoses after Solid Organ Transplantation: A Comprehensive Review

Neurological complications of SARS-CoV-2 infection among solid organ transplanted patients: does immunosuppression matter?

Strongyloides stercoralis infection in solid organ transplant recipients

Clinical approach to donor‐derived infection in solid organ transplant recipients

Intracerebral opportunistic infections caused by immunosuppressants after orthotopic liver transplantation: Report of two cases and literature review

The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation

Neurocritical Care in Transplant Patients

Impact of solid organ transplant status on outcomes of hospitalized patients with COVID‐19 infection

Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation.

Bacterial infections in solid organ transplant recipients

Nocardia infections in solid organ transplantation: Guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation

Brain abscess following solid organ transplantation: A 21‐year retrospective study

The changing landscape of infections in the lung transplant recipient

Cytomegalovirus Retinitis in the Modern Era of Solid Organ Transplantation

Invasive Fungal Infections in Inpatient Solid Organ Transplant Recipients With COVID-19: A Multicenter Retrospective Cohort

Long‐term outcomes after COVID‐19 infection in transplant recipients